Key result
Trial protocol details evaluation of CVD biomarkers and composite vascular events.
Why the study?
It is unclear whether a brief DASH diet screener score can capture improvements in cardiovascular biomarkers and vascular events in secondary prevention of stroke.
Does a brief DASH diet screener score associate with improvements in CVD biomarkers and a composite of vascular events in a secondary stroke prevention setting?
RCT
Does a brief DASH diet screener score associate with improvements in CVD biomarkers and a composite of vascular events in a secondary stroke prevention setting?
Leaves clinical question on DASH screener in stroke prevention unresolved; further studies needed before any practice consideration.
Objectives: Greater adherence to the DASH diet is linked to lower cardiovascular disease (CVD) risk. However, it is unclear whether a brief DASH screener that reflects diet adherence can also capture improvements in CVD biomarkers and hard outcomes in secondary prevention settings. We aimed to determine the associations of a DASH screener score with CVD biomarkers and a composite of vascular events in the Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis trial.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2026) conducted an RCT in Intracranial Stenosis / Stroke Recurrence. DASH diet screener score was evaluated on CVD biomarkers and a composite of vascular events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: